The Efficacy and Safety of Subcutaneous Ixekizumab for the Treatment of Axial Spondylarthritis: A Systematic Review and Meta-Analysis

Axial spondylarthritis (axSpA) is a progressive inflammatory condition that is treated with various management options. Interleukin-17A (IL-17A) inhibitors are a novel therapeutic option that demonstrates both efficacy and safety. This systematic review and meta-analysis evaluated the effectiveness...

Descripción completa

Detalles Bibliográficos
Autores principales: Alzahrani, Ziyad, Bashrahil, Bader A, Alzahrani, Rakan, Alharthy, Fayez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039670/
https://www.ncbi.nlm.nih.gov/pubmed/36974243
http://dx.doi.org/10.7759/cureus.35360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039670/
https://www.ncbi.nlm.nih.gov/pubmed/36974243
http://dx.doi.org/10.7759/cureus.35360

Ejemplares similares